Investment thesis
With the recent launch of Liquid Biopsy, China expansion, machine learning platform later in the year and a slight pivot to attempting to sell population sequencing to more countries, Personalis has become an even more enticing opportunity.
Developments since IPO
On June 7, 2019 I published an article about PSNL doing a basic analysis of the company at the time of its IPO. Over the past 14 months since I wrote the article, the company has kept up a steady pace of announcements and innovations and going from strength to strength in its